NASDAQ: AKTSAkoustis Technologies Inc Stock
$0.74-0.03 (-3.9%)
Updated Sep 22, 2023
AKTS Price
$0.74
Fair Value Price
$1.51
Market Cap
$53.47M
52 Week Low
$0.70
52 Week High
$4.96
P/E
-0.74x
P/B
0.62x
P/S
7.46x
PEG
N/A
Dividend Yield
N/A
Revenue
$27.12M
Earnings
-$63.56M
Gross Margin
-11.5%
Operating Margin
-234.81%
Profit Margin
-234.3%
Debt to Equity
0.73
Operating Cash Flow
-$45M
Beta
1.45
Next Earnings
Nov 13, 2023
Ex-Dividend
N/A
Next Dividend
N/A
AKTS Overview
Akoustis Technologies, Inc., through its subsidiary, Akoustis, Inc., develops, designs, manufactures, and sells radio frequency (RF) filter products for the mobile wireless device industry in the United States. It operates through two segments, Foundry Fabrication Services and RF Filters. The Foundry Fabrication Services segment provides engineering review services; and semiconductor wafer-manufacturing and microelectromechanical systems foundry services. The RF Filters segment consists of amplifier and filter products. It offers RF filters for mobile wireless devices, such as smartphones and tablets, cellular infrastructure equipment, Wi-Fi customer premise equipment, and military and defense applications. The company was incorporated in 2013 and is headquartered in Huntersville, North Carolina.
Zen Score
–
Industry Average (35)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how AKTS scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
AKTS ($0.74) is undervalued by 51.12% relative to our estimate of its Fair Value price of $1.51 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
AKTS ($0.74) is significantly undervalued by 51.12% relative to our estimate of its Fair Value price of $1.51 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
AKTS is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more AKTS due diligence checks available for Premium users.
Be the first to know about important AKTS news, forecast changes, insider trades & much more!
AKTS News
Valuation
AKTS fair value
Fair Value of AKTS stock based on Discounted Cash Flow (DCF)
Price
$0.74
Fair Value
$1.51
Undervalued by
51.06%
AKTS ($0.74) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
AKTS ($0.74) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
AKTS is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
AKTS price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.74x
Industry
16.83x
Market
14.52x
AKTS price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.62x
Industry
3.02x
AKTS is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
AKTS's financial health
Profit margin
Revenue
$8.3M
Net Income
-$17.8M
Profit Margin
-213.2%
AKTS's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
AKTS's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$148.9M
Liabilities
$62.7M
Debt to equity
0.73
AKTS's short-term assets ($59.85M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
AKTS's short-term assets ($59.85M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
AKTS's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
AKTS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$8.7M
Investing
-$1.2M
Financing
$272.0k
AKTS's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
AKTS vs Communication Equipment Stocks
Akoustis Technologies Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.